Purpose
A self-sufficient, mainstream and wonderful life for the child determines the abilities, goals, people, methods, everyday practice and review.
Evidence libraryPINNACLEAI® · THE COMPLETE STORY
A life-first purpose. A documented Indian medical-device foundation. A new chapter in international readiness.
PinnacleAI® brings developmental ability measurement, readiness tracking, progress forecasting and adaptive therapy-plan support into the child’s journey—with families and professionals at its heart.
Source-linked editorial review ·

THE PURPOSE
A self-sufficient, mainstream and wonderful life for the child determines the abilities, goals, methods, people, practice and review.
That means beginning with the life a child is working toward: communicating, learning, making choices, joining in, building confidence and becoming increasingly independent. A score can inform the next step; the child’s life gives that step its purpose.
A self-sufficient, mainstream and wonderful life for the child determines the abilities, goals, people, methods, everyday practice and review.
The seven-stage pathway connects capability identification and AbilityScore® measurement with readiness forecasting and a child-specific plan.
Integrated intervention, parent-guided practice, progress review and reassessment work toward growing independence and participation.
PinnacleAI® supports the pathway as licensed non-diagnostic developmental-support software with human and professional review.
THE SEVEN-STAGE PATHWAY
The pathway connects professional support with practice at home and review over time. Goals and pace remain individual to each child.
Identify capabilities and measure ability
Forecast readiness and create a child-specific plan
Provide integrated therapies and intervention
Support parent-guided everyday practice and home generalisation
Track progress and correct the plan
Reassess and repeat until readiness
Support growing independence, school readiness and mainstream participation
THE SOFTWARE’S ROLE
The manufacturing licence names four intended functions. These support measurement, planning and review by the people involved in the child’s development.
Organise observations of a child’s abilities so the starting point and goals can be discussed.
Follow readiness for participation and everyday goals through repeated review.
Support planning with forecasts that are considered alongside professional judgement.
Support review and adjustment of the child-specific plan as information changes.
People remain central. Parents, therapists, educators and caregivers are the intended users. The product is non-diagnostic; clinical and care decisions remain within appropriate human and professional review.
The BIS scope schedule names AbilityScore mapping, Prognose, Everyday Therapy through TherapeuticAI, and tracking and correction through Fusion. These names describe the documented software scope; each child’s goals and outcomes are individual.
THE INDIAN REGULATORY FOUNDATION
Each document answers a different question: what the licensed device does, who manufactures it, which management systems are certified, and what the export certificate establishes.
The operative MD-5 identifies the device as Class B.
The separate issued classification decision is still sought in this collection; the manufacturing licence is the inspected basis for the Class B description.
Inspect the source recordMFG/MD/2026/000248 · instrument dated 21 April 2026
Names the manufacturer, product, version and non-diagnostic intended use. The FSC cites the base licence date as 20 April; each source is reproduced as printed.
Inspect the source recordMedical-device quality-management system
Read the certificate’s named entity, scope and dates. Management-system certification is distinct from a child’s clinical outcome.
Inspect the source recordInformation-security management system
Describes the information-security management system within the certificate’s stated scope. Read the named entity, covered activities and validity dates together.
Inspect the source recordMD/L-2026029599 · 3 September 2026
The schedule names AbilityScore mapping, Prognose, Everyday Therapy through TherapeuticAI, and tracking and correction through Fusion within the certified scope.
Inspect the source recordFSC/MD/2026/000741 · 23 September 2026
Records Indian domestic marketability and export of the licensed device subject to the importing country’s law.
Inspect the source record23 SEPTEMBER 2026 · THE EXPORT MILESTONE
Free Sale Certificate FSC/MD/2026/000741 adds a documented export foundation to the licensed PinnacleAI product.
Issued by the State Licensing Authority, TG SAFE, Telangana, on 23 September 2026, the certificate references manufacturing licence MFG/MD/2026/000248. It records that the listed device may be manufactured and sold in India under Indian law and exported as per the law of the importing country.
For potential international partners, the practical value is an inspectable source package: product identity, intended use, manufacturer, licence, management-system scope and the export certificate. Market access then proceeds under each destination’s requirements.
Read the public certificate · Read the forwarding letter
Indian export documentation is established. A foreign registration or marketing authorisation is a separate, country-specific step.

RESEARCH THAT READERS CAN INSPECT
The research library brings together seven canonical works: six preprints and one report. The records preserve authorship, versions, publication status, original files and reuse licences. Three useful starting points for the PinnacleAI story are:
Preprint · regulatory analysis
Koti Reddy Saripalli’s documentary analysis of the April 2026 licensing case against later CDSCO guidance. It helps readers follow the regulatory reasoning; it is not an efficacy study.
Preprint · preliminary technical monograph
Explains the measurement approach and preliminary within-network analysis. Read the methods, sample definitions and limitations with the reported findings.
Preprint · study protocol
Sets out a proposed validation study. A protocol describes planned work; completed external-validation results require their own report.
Research evidence and regulatory documents answer different questions. The library identifies what is preliminary, what is planned and what has been reported, so a reader can assess each work on its own terms.
Explore all research, books and author profiles · Check the claim-to-source ledger
DOCUMENTED SCALE · 17 JULY 2026
The dated SRS 4400 factual-findings report records the following distinct measures:
These figures describe different units at the report date. They provide context for the organisation’s work; they should not be combined into a single child-outcome measure or presented as today’s centre count.
Read the definitions and source pages · Explore scale and mission
INTERNATIONAL LICENSING PATHWAY
Pinnacle’s announcement identifies ten target markets. The next chapter is to translate the Indian source package into country-specific requirements, applications and—where issued—registrations.
| Market | Current documented stage |
|---|---|
| New Zealand | Announced target |
| United Kingdom | Announced target |
| Brazil | Announced target |
| Vietnam | Announced target |
| Thailand | Announced target |
| Colombia | Announced target |
| Peru | Announced target |
| Saudi Arabia | Announced target |
| Canada | Announced target |
| Australia | Announced target |
Filing receipts and foreign registrations are not yet verified in this collection. A market advances to “submitted” when a receipt is available and to “registered” when the competent authority’s record is available. The announced MDSAP audit plan remains a plan until scheduling and completion are evidenced; country market access is separate.
YOUR NEXT STEP
Discuss your child’s abilities, goals and the support that could help in everyday life. Pinnacle’s National Autism Helpline offers free guidance, 24/7.
Call 9100 181 181Operated by Pinnacle Blooms Network / Bharath Healthcare Laboratories Private Limited. Free guidance is separate from assessment and therapy fees; normal call charges may apply.
Begin with the intended use, technical scope and research methods. For an international enquiry, include the country and the product or document you wish to discuss.
Contact the Pinnacle team · Organisation and source contacts
Use the source map below to keep product, research and market-access claims traceable.
QUESTIONS FROM FAMILIES AND PARTNERS
PinnacleAI® GPT-OS v1.0.0 is identified in the supplied Indian manufacturing licence as Class B, non-diagnostic developmental-support software for children aged 0–12. Its stated functions include developmental ability measurement, readiness tracking, progress forecasting and adaptive therapy-plan support.
Bharath Healthcare Laboratories Private Limited is the licence holder and legal manufacturer named in the reviewed regulatory records. Pinnacle Blooms Network is the child-development brand and service ecosystem.
FSC/MD/2026/000741 records Indian domestic marketability and export eligibility for the licensed device. It supports country-specific market-access applications; it is not approval or registration in another country.
No. The licensed product is described as non-diagnostic developmental-support software. Clinical and care decisions remain within the appropriate human and professional review process.
This page does not claim a foreign registration. Each market will be labelled researching, representative appointed, technical file prepared, submitted, under review or registered only when the corresponding evidence is available.
Use the citation downloads and machine-readable JSON or text exports. Cite the exact licence, certificate or dated report for a specific claim and retain its date and scope.
Pinnacle uses GPT-OS in its product name and describes an approach spanning measurement, planning, everyday practice and review. The regulatory description is non-diagnostic developmental-support software; “operating system” is not a separate regulatory approval category.
The Free Sale Certificate documents the device’s regulatory standing in India and supports international market-access work. For your child, the useful questions remain the individual goals, the care team, everyday practice, progress review and the relevant centre’s records.
Call Pinnacle’s National Autism Helpline on 9100 181 181 for free guidance, available 24/7. The service is operated by Pinnacle Blooms Network / Bharath Healthcare Laboratories Private Limited. Free guidance is separate from assessment or therapy charges; normal call charges may apply.
CLAIM TO ORIGINAL SOURCE
Use this map when writing about PinnacleAI. Preserve the date, named entity, intended use and source scope.
| Claim | Source and scope |
|---|---|
| Class B, non-diagnostic developmental-support software; version 1.0.0; children aged 0–12 | Issued manufacturing licence and annexure; intended use, not diagnostic or outcome authority. Open the supporting record |
| Developmental ability measurement, readiness tracking, progress forecasting and adaptive therapy-plan support | Licensed intended functions; human and professional review remains part of care. Open the supporting record |
| Bharath Healthcare Laboratories Private Limited is the licence holder and manufacturer | Legal entity differs from the Pinnacle Blooms Network brand. Open the supporting record |
| BIS licence MD/L-2026029599 dated 3 September 2026 | Read the management-system scope schedule and dates. Open the supporting record |
| FSC/MD/2026/000741 issued 23 September 2026 | Domestic marketability and export subject to importing-country law; not foreign registration. Open the supporting record |
| 31,052,382 defined cumulative services; 792,614 beneficiary/family registrations; >2.7 billion structured records; 49 operationally defined centres | SRS 4400 factual-findings report dated 17 July 2026; distinct units and definitions, not an outcome denominator. Open the supporting record |
| Research preprints, a study protocol and their source files are publicly inspectable | Repository publication does not imply peer review, efficacy or regulator endorsement. Open the supporting record |
| Ten international markets are announced targets | Organisation announcement of 24 September 2026; filings and registrations not verified in this collection. Open the supporting record |
Download the source map · CSV · Structured story · JSON · Complete story · plain text
Bharath Healthcare Laboratories Private Limited. (2026, September 24). PinnacleAI®: the complete story—purpose, research and export readiness. Pinnacle Verify. https://www.pinnacleblooms.org/verify/evidence/pinnacleai-regulatory-journey.html
This is a first-party, source-linked narrative. For a regulatory or research finding, cite the linked original record and its scope. This editorial expansion does not carry a new independent clinical review.
Text · BibTeX · RIS · CSL-JSON · Narrative evidence record · Full citation library
Pinnacle Blooms Network is a brand of Bharath Healthcare Laboratories Private Limited. View legal identity evidence.